Diabetes in adults and old age. Treatment with an oral antidiabetic agent
Behpour, A.
Zfa. Zeitschrift für Allgemeinmedizin 56(22): 1412-1414
1980
ISSN/ISBN: 1433-6251 PMID: 7424146 Document Number: 160904
Document emailed within 1 workday
Related Documents
Sieberová, R. 1971: Clinical experiences with administration of oral antidiabetic agent Buformin Casopis Lekaru Ceskych 110(18): 420-421Uglesic, A.; Ljahnicky, N. 1975: Experiences with the oral antidiabetic agent, Glurenorm, in diabetics with kidney diseases Medizinische Monatsschrift 29(9): 408-411
Leubner, H. 1973: Results of a clinical test on the oral antidiabetic agent glibornuride (Ro 6-4563) Wiener Medizinische Wochenschrift 123(17): 277-282
D'Onofrio, F.; Pempinello, R.; Romis, L. 1972: Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide Arzneimittel-Forschung 22(11): 1879-1881
Schmitt, E.W.; Nijssen, J. 1978: Glibornuride--field study on an oral antidiabetic agent. Results of therapy with gluboride in a large number of patients Die Medizinische Welt 29(29-30): 1170-1174
Voss, D.; Fuchs, G.; Schneider, D.; Schneider, J. 1972: Effect of the oral antidiabetic agent glibornuride on blood coagulation, blood platelets, and fibrinolysis Arzneimittel-Forschung 22(Suppl 12a): 2219
Kuritzky, L. 2006: Addition of basal insulin to oral antidiabetic agents: a goal-directed approach to type 2 diabetes therapy Medgenmed: Medscape General Medicine 8(4): 34
Oh, J.; Gjelsvik, A.; Fuller, D.; Walsh, E.; Paine, V.; Leonard, L. 2012: Less than optimal dental care among Rhode Island adults with diabetes: the need to assure oral health care for all adults with diabetes Medicine and Health Rhode Island 95(3): 91-93
Panikar, V.; Joshi, S.R.; Deogaonkar, N.; Vadgama, J.; Nasikkar, N.; Kamat, T.; Sheikh, S.; Jain, C.C.; Wagle, T. 2018: Efficacy of SGLT2 Inhibitors as the Fifth Drug in the Management of Type 2 Diabetes Mellitus in Asian Indians not Controlled with at least 4 Oral Antidiabetic Drugs Journal of the Association of Physicians of India 66(12): 46-49
Pandya, J.K.; Jhala, C.I.; Goel, R.K. 1983: Antidiabetic treatment and coxsackie virus in diabetes Indian Journal of Pathology and Microbiology 26(2): 71-75
Schroner, Z.; Javorsky, M.; Kozarova, M.; Tkac, I. 2011: Pharmacogenetics of oral antidiabetic treatment Bratislavske Lekarske Listy 112(8): 441-446
Schumm-Draeger, P-Maria. 2006: Current treatment with oral antidiabetic agents MMW Fortschritte der Medizin 148(9): 33-35
Karásek, D. 2017: The effect of antidiabetic treatment on the bone of patients with type 2 diabetes Vnitrni Lekarstvi 62(7-8): 582-587
Fabian, Wława.; Majkowska, L.; Stefański, A.; Moleda, P. 2005: Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners Przeglad Lekarski 62(4): 201-205
Thomas Schöndorf; Forst, T.; Flohberg, C.; Georg Lübben; Armbruster, F.P.; Roth, W.; Borchert, M.; Christiane Köder; Mirjam Löbig; Grabellus, M.; Pf, A.ützner 2007: Relaxin Expression Correlates Significantly with Serum Changes in VEGF in Response to Antidiabetic Treatment in Male Patients with Type 2 Diabetes mellitus Clinical Laboratory 53(3-4): 193-198
Maeshiba, Y.; Kiyota, Y.; Yamashita, K.; Yoshimura, Y.; Motohashi, M.; Tanayama, S. 1997: Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys Arzneimittel-Forschung 47(1): 29-35
Grujić, M.; Rizvanbegović, B.; Perinović, M.; Perinović, I.D. 1976: Glurenorm a new peroral antidiabetic agent belonging to the group of sulfonylurea compounds Medicinski Arhiv 30(2): 119-121
Olson, D.E.; Norris, S.L. 2004: Diabetes in older adults. Overview of AGS guidelines for the treatment of diabetes mellitus in geriatric populations Geriatrics 59(4): 18-24; Quiz 25
Hepp, K.D. 1983: Fenfluramine as an oral antidiabetic Münchener Medizinische Wochenschrift 125(46): 126-127
Johansen, K. 2001: New oral antidiabetic glitazones Ugeskrift for Laeger 164(1): 76-77